Issue Information

ISTH Academy, Faculty / Presenters, 4150303

Assessment of antibodies against platelet factor 4 following vaccination with adenovirus type 26–vectored vaccines

ISTH Academy, , 4150327

Factors associated with venous thromboembolism pharmacoprophylaxis initiation in hospitalized medical patients: the Medical Inpatients Thrombosis and Hemostasis study

ISTH Academy, Faculty / Presenters, 4150326

Development of an assay using a modified coagulation factor V to measure protein S activity

ISTH Academy, Koichi Kokame, 4150325

Treatment of atrial fibrillation and venous thromboembolism with factor Xa inhibitors in severely obese patients

ISTH Academy, Faculty / Presenters, 4150324

Anxiety in patients with venous thromboembolism: quantification and risk factors in a prospective cohort study

ISTH Academy, Cihan Ay, 4150323

Anticoagulation for splanchnic vein thrombosis in myeloproliferative neoplasms: a systematic review and meta-analysis

ISTH Academy, Rushad Patell, 4150322

Estimation of gestational age-specific reference intervals for coagulation assays in a neonatal intensive care unit using real-world data

ISTH Academy, , 4150321

Genetic variants, thrombocytopenia, and clinical phenotype of type 2B von Willebrand disease: a median 16-year follow-up study

ISTH Academy, Frank Leebeek, 4150320

Bivariate genome-wide association study of circulating fibrinogen and C-reactive protein levels

ISTH Academy, Paul de Vries, 4150319

Clinical validation and application of targeted long-range polymerase chain reaction and long-read sequencing–based analysis for hemophilia: experience from a hemophilia treatment center in China

ISTH Academy, , 4150318

Lack of factor VIII detection in humans and dogs with an intron 22 inversion challenges hypothesis regarding inhibitor risk

ISTH Academy, Kathleen Pratt, 4150317

JTH in Clinic: management of low-risk pulmonary embolism

ISTH Academy, Geoff Barnes, 4150316

Shifting focus from venous to arterial thromboembolism in patients with cancer

ISTH Academy, Nick Van Es, 4150315

Intron 22 inversions: cross-reactive material or no cross-reactive material?

ISTH Academy, Bhavya Doshi, 4150314

The eccentric nature of the neointima

ISTH Academy, , 4150313

Meta-analyzing antithrombotic therapy in myeloproliferative neoplasm–related splanchnic vein thrombosis: a first step in understanding a rare complication of a rare disease

ISTH Academy, , 4150312

HMGB1 in platelets: a viable therapeutic target?

ISTH Academy, , 4150311

The evolving landscape of von Willebrand disease diagnosis

ISTH Academy, Brooke Sadler, 4150310

Low von Willebrand factor—unraveling an enigma wrapped in a conundrum

ISTH Academy, Faculty / Presenters, 4150309

Viral coagulation: pushing the envelope

ISTH Academy, Faculty / Presenters, 4150308

Endothelial colony-forming cells in the spotlight: insights into the pathophysiology of von Willebrand disease and rare bleeding disorders

ISTH Academy, Ruben Bierings, 4150307

The changing face of cerebral venous sinus thrombosis—emerging new causes and treatments

ISTH Academy, , 4150306

Platelet HMGB1 steers intravascular immunity and thrombosis

ISTH Academy, Faculty / Presenters, 4150305

Interdisciplinarity within thrombosis and hemostasis: opportunities for early career professionals to find their niche

ISTH Academy, Lauren Poole, 4150304

Case Consult: Optimizing the Management of cTTP

ISTH Academy, Faculty / Presenters, 4147458

Treating ITP: Working Together to Improve Outcomes

ISTH Academy, Faculty / Presenters, 4147459

Factor XI/XIa Inhibition: Ensuring Safety and Efficacy

ISTH Academy, Faculty / Presenters, 4147457

Gene therapy for people with hemophilia B: a proposed care delivery model in Italy

ISTH Academy, Flora Peyvandi, 4147916

Production of physiological amounts of hemostatic proteins by human donor livers during ex situ long-term normothermic machine perfusion for up to 7 days

ISTH Academy, Ton Lisman, 4147917

Evaluating the safety and effectiveness of direct oral anticoagulants compared with warfarin in very elderly patients with atrial fibrillation with and without low bodyweight

ISTH Academy, Faculty / Presenters, 4147918

Biomarker-enhanced cardiovascular risk prediction in patients with cancer: a prospective cohort study

ISTH Academy, , 4147919

Development of A structured integrated post-Pulmonary Embolism care model: The Attend-PE model

ISTH Academy, Faculty / Presenters, 4147920

Very long–term risk of moderate-to-severe postthrombotic syndrome after deep vein thrombosis

ISTH Academy, Faculty / Presenters, 4147921

Elevated lipopolysaccharide level is largely driven by time since symptom onset in acute ischemic stroke: the impact on clinical outcomes

ISTH Academy, Anetta Undas, 4147922

Universal clinical decision support tool for thromboprophylaxis in hospitalized COVID-19 patients: post hoc analysis of the IMPROVE-DD cluster randomized trial

ISTH Academy, , 4147923

Hereditary antithrombin deficiency pilot project registry from the American Thrombosis and Hemostasis Network

ISTH Academy, Faculty / Presenters, 4147924

Hepatocyte-independent PAR1-biased signaling controls liver pathology in experimental obesity

ISTH Academy, James Luyendyk, 4147925

Impaired fibrinolysis in JAK2V617F-related myeloproliferative neoplasms

ISTH Academy, Faculty / Presenters, 4147926

Fibrinolysis is impaired in patients with primary immune thrombocytopenia

ISTH Academy, Johanna Gebhart, 4147927

Brain-derived gangliosides prime human platelet aggregation and induce platelet-leukocyte aggregate formation

ISTH Academy, Faculty / Presenters, 4147928

Targeting cargo to an unconventional secretory system within megakaryocytes allows the release of transgenic proteins from platelets

ISTH Academy, Joseph Italiano, 4147929

Novel GPIb-independent platelet aggregation induced by botrocetin: implications for diagnosis and antithrombotic therapy

ISTH Academy, Heyu Ni, 4147930

CpG oligonucleotides induce acute murine thrombocytopenia dependent on toll-like receptor 9 and spleen tyrosine kinase pathways

ISTH Academy, John Semple, 4147931

Atomistic characterization of β2-glycoprotein I domain V interaction with anionic membranes

ISTH Academy, Emad Tajkhorshid, 4147932

Small molecules targeting GRP78 mitigate anti-GRP78 autoantibody–mediated tissue factor procoagulant activity in cultured endothelial cells

ISTH Academy, , 4147933

Endothelial protein disulfide isomerase A1 enhances membrane stiffness and platelet-endothelium interaction in hyperglycemia via SLC3A2 and LAMC1

ISTH Academy, Faculty / Presenters, 4147934

The use of direct oral anticoagulants in the secondary prevention of venous thromboembolism in patients with severe thrombophilia: communication from the ISTH SSC Subcommittee on Physiological Anticoagulants and Thrombophilia

ISTH Academy, Faculty / Presenters, 4147935

Corrigendum to ‘COVID-19 outcomes in persons with hemophilia: results from a US-based national COVID-19 surveillance registry’ [Journal of Thrombosis and Haemostasis Volume 22, Issue 1, January 2024, Pages 61-75]

ISTH Academy, Faculty / Presenters, 4147936

Annoucements

ISTH Academy, Faculty / Presenters, 4147937

Comparing rates of clinically relevant epistaxis in patients taking warfarin versus direct oral anticoagulants

ISTH Academy, Faculty / Presenters, 4151067

Rapid and ordered cleavage of prothrombin by Hopsarin D in the absence of phospholipid membranes

ISTH Academy, James Huntington, 4147915

Rapid diagnosis of coagulopathies from vitamin K deficiency in a consecutive case cohort evaluated by comparative assessment of factor II by 1-stage assays with prothrombin time vs Ecarin reagents

ISTH Academy, Catherine Hayward, 4147914

Sensitivity and specificity of strategies to identify patients with hemostasis abnormalities leading to an increased risk of bleeding before scheduled intervention: the Hemorisk study

ISTH Academy, Faculty / Presenters, 4147913

Evaluating clinically translatable conditioning for platelet gene therapy in murine hemophilia A with inhibitors

ISTH Academy, Qizhen Shi, 4147912

Unravelling the spectrum of von Willebrand factor variants in quantitative von Willebrand disease: results from a German cohort study

ISTH Academy, Faculty / Presenters, 4147911

A new track for KDELivery of designer cargo by platelets

ISTH Academy, Freda Passam, 4147910

The molecular background of quantitative defects of von Willebrand factor

ISTH Academy, Ferdows Atiq, 4147909

Epidemiology, natural history, diagnosis, and management of ovarian vein thrombosis: a scoping review

ISTH Academy, Stephane Zuily, 4147908

Coagulation protease–induced extracellular vesicles: their potential effects on coagulation and inflammation

ISTH Academy, L Vijaya Mohan Rao, 4147907

Targeted treatments for vascular malformations: current state of the art

ISTH Academy, Miikka Vikkula, 4147906

Adeno-associated viral vector integration: implications for long-term efficacy and safety

ISTH Academy, Faculty / Presenters, 4147905

Recognizing the 11th Year of World Thrombosis Day: A Call to Action for Health Care Professionals with a Focus on Women and Thrombosis

ISTH Academy, , 4147904

Issue Information

ISTH Academy, Faculty / Presenters, 4147903

International normalized ratio measurement during perioperative anticoagulation bridging with low-molecular-weight heparin in patients undergoing heart valve replacement surgery

ISTH Academy, An Stroobants, 4151066

Impact of self-reported race on Villalta Scale postthrombotic syndrome scores and correlation with venous disease-specific quality of life: an exploratory analysis of the Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis Trial

ISTH Academy, Susan Kahn, 4151065

Primary thromboprophylaxis in ambulatory symptomatic patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials

ISTH Academy, Faculty / Presenters, 4151064

Nonneutralizing antibodies in Nordic persons with moderate hemophilia A and B (the MoHem study)

ISTH Academy, Faculty / Presenters, 4151063

Development and internal validation of a simple clinical score for the estimation of the probability of deep vein thrombosis in outpatient emergency department patients

ISTH Academy, Faculty / Presenters, 4151062

Complement-mediated hemolytic uremic syndrome associated with postpartum hemorrhage: case series and systematic review of individual participant data

ISTH Academy, Faculty / Presenters, 4151061

Stability of the thromboxane B biomarker of low-dose aspirin pharmacodynamics in human whole blood and in long-term stored serum samples

ISTH Academy, Faculty / Presenters, 4151060

Maternal thrombocytopenia is not predictive of neonatal thrombocytopenia: a single-center Irish study

ISTH Academy, Faculty / Presenters, 4151059

Efficacy, safety, and quality of life 4 years after valoctocogene roxaparvovec gene transfer for severe hemophilia A in the phase 3 GENEr8-1 trial

ISTH Academy, Faculty / Presenters, 4151058

The influence of severity of hemophilia on bone mineral density and fracture risk

ISTH Academy, Faculty / Presenters, 4151056

Outcomes of patients with acute pulmonary embolism managed in-house vs those transferred between hospitals: a retrospective observational study

ISTH Academy, , 4151057

Bleeding disorder of unknown cause: an illustrated review on current practice, knowledge gaps, and future perspectives

ISTH Academy, Floor Heubel-Moenen, 4151043

Prophylaxis in von Willebrand disease with von Willebrand factor concentrate and nonfactor therapies

ISTH Academy, Frank Leebeek, 4151044

Risk factors for neurologic sequelae in children and adolescents with hemophilia after intracranial hemorrhage

ISTH Academy, Faculty / Presenters, 4151045

External validation of the Leiden Thrombosis Recurrence Risk Prediction models (L-TRRiP) for the prediction of recurrence after a first venous thrombosis in the Heart and Vascular Health study

ISTH Academy, Suzanne Cannegieter, 4151046

Inhibitor development upon switching from plasma-derived to recombinant factor VIII in previously untreated patients with severe hemophilia A: the PUP-SWITCH study

ISTH Academy, Flora Peyvandi, 4151047

Incidence and risk factors of ischemic stroke in patients with cancer-associated venous thromboembolism: from the Contemporary Management and Outcomes in Patients With Venous Thromboembolism Registry-2

ISTH Academy, Faculty / Presenters, 4151048

Hemostatic conditions following autologous transfusion of fresh vs stored platelets in experimental endotoxemia: an open-label randomized controlled trial with healthy volunteers

ISTH Academy, Faculty / Presenters, 4151049

Oral invasive procedures in Glanzmann thrombasthenia: a retrospective observational study

ISTH Academy, Faculty / Presenters, 4151050

Utilizing artificial intelligence for the detection of hemarthrosis in hemophilia using point-of-care ultrasonography

ISTH Academy, , 4151051

Complex immunogenicity assessment in caplacizumab-treated patients with immune-mediated thrombotic thrombocytopenic purpura who have received plasma exchange

ISTH Academy, Faculty / Presenters, 4151052

Dependence of clot structure and fibrinolysis on apixaban and clotting activator

ISTH Academy, , 4151053

The anticoagulant effects of milvexian, a novel small molecule factor XIa inhibitor, are neutralized by activated prothrombin complex concentrates and recombinant factor VIIa in human plasma and whole blood in vitro

ISTH Academy, Madhu Chintala, 4151054

In-depth characterization of N-glycosylation and sialic acid content in fetal and adult fibrinogen

ISTH Academy, Ashley Brown, 4151055

Monitoring and Reversal for Factor Xa Inhibitors

ISTH Academy, Faculty / Presenters, 4145875

Research Careers Outside Academia

ISTH Academy, Faculty / Presenters, 4144121

Anticoagulation for stroke prevention in AFib and treatment of VTE and PVT in cirrhosis

ISTH Academy, Faculty / Presenters, 4147521

Advancing Women's Health: Understanding Thrombosis

ISTH Academy, Faculty / Presenters, 4147561

Gene Therapy in Hemophilia: Clinical Care Strategies for Gene Therapy

ISTH Academy, Faculty / Presenters, 4144127

Tinzaparin, an alternative to subcutaneous unfractionated heparin, in patients with severe and end-stage renal impairment: a retrospective observational single-center study

ISTH Academy, Faculty / Presenters, 4147429

Utility of thromboelastography with platelet mapping for monitoring platelet transfusion in qualitative platelet disorders

ISTH Academy, Wolfgang Bergmeier, 4147430

Vascular endothelial-cadherin is involved in endothelial cell detachment during thrombotic thrombocytopenic purpura

ISTH Academy, Faculty / Presenters, 4147431

Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH

ISTH Academy, Faculty / Presenters, 4147432

Examining variability in the diagnosis and management of people with bleeding disorders of unknown cause: communication from the ISTH SSC Subcommittee on von Willebrand Factor

ISTH Academy, Michelle Lavin, 4147433

Comparison of assays measuring extracellular vesicle tissue factor in plasma samples: communication from the ISTH SSC Subcommittee on Vascular Biology

ISTH Academy, Faculty / Presenters, 4147434

Prospective, international, multisite comparison of platelet isolation techniques for genome-wide transcriptomics: communication from the SSC of the ISTH

ISTH Academy, Matthew Rondina, 4147435